Maternal mortality in pregnant women with positive SARS-CoV-2 antibodies and severe preeclampsia. Report of 3 cases

Authors

  • Jorge Arturo Collantes Cubas Obstetrician-gynecologist; Hospital Regional Docente de Cajamarca, Perú
  • Segundo Alberto Pérez Ventura Obstetrician-gynecologist; Hospital Regional Docente de Cajamarca, Perú
  • Paulino Vigil - De Gracia Obstetrician-gynecologist, Department of Obstetrics; Complejo Hospitalario Dr. Arnulfo Arias Madrid. Caja de Seguro Social, Panamá, Panamá
  • Karla Esperanza Castañeda Bazán Neurologist, Department of Neurology; Hospital Regional Docente de Cajamarca, Perú
  • Juan Martín Tapia Saldaña Radiologist, Department of Radiology; Hospital Regional Docente de Cajamarca, Perú
  • Francisco Jose Leyva Clinical Pharmacologist, Maryland USA; NIAID-National Institutes of Health, Maryland, EEUU

DOI:

https://doi.org/10.31403/rpgo.v66i2279

Keywords:

Maternal mortality, Preeclampsia, Eclampsia, HELLP syndrome, COVID-19, Stroke, Diabetes mellitus

Abstract

Maternal mortality from COVID-19 is rare in developed countries, but its association with other obstetric complications increases the risk. It is also associated with fetal death. Postpartum women are at risk of thrombosis that increases with COVID-19 coagulopathy. Comorbidities such as obesity, diabetes, and hypertension increase the risk of death from COVID-19, and pregnant women have more complications during the third trimester than in the first trimester, with higher risk than nonpregnant women of entering the ICU and requiring mechanical ventilation. In this report, stroke, diabetes and intracerebral hemorrhage were the three causes of death described, all within the context of stillbirth, severe preeclampsia, eclampsia and/or HELLP syndrome.

Downloads

Download data is not yet available.

Published

2020-11-09

How to Cite

Collantes Cubas, J. A., Pérez Ventura, S. A., Vigil - De Gracia, P., Castañeda Bazán, K. E., Tapia Saldaña, J. M., & Leyva, F. J. (2020). Maternal mortality in pregnant women with positive SARS-CoV-2 antibodies and severe preeclampsia. Report of 3 cases. The Peruvian Journal of Gynecology and Obstetrics, 66(3). https://doi.org/10.31403/rpgo.v66i2279

Issue

Section

Casos Clínicos

Most read articles by the same author(s)